MYOCARDIAL FIBROSIS

This adverse event was reported 840 times

These drugs are most commonly taken by patients reporting MYOCARDIAL FIBROSIS:

# Drug Count
0 ACETAMINOPHEN 64
1 LORAZEPAM 63
2 METHADONE 59
3 ACETAMINOPHEN 500MG 58
4 ACETAMINOPHEN TABLET EXTENDED RELEASE 58
5 PAIN RELIEVER 58
6 CLOZAPINE 54
7 DIAZEPAM 54
8 DIAZEPAM ORAL 50
9 DIAZEPAM ORAL SOLUTION (CONCENTRATE) 50
See all common drugs associated with MYOCARDIAL FIBROSIS

MYOCARDIAL FIBROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 COCAINE HYDROCHLORIDE NASAL 1 0.0154
1 MIGALASTAT HYDROCHLORIDE 4 0.0072
2 SODIUM SULFACETAMIDE 1 0.0055
3 DELANDISTROGENE MOXEPARVOVEC-ROKL 2 0.0054
4 GADODIAMIDE 13 0.0039
5 LIFILEUCEL 1 0.0035
6 GADOTERIDOL 6 0.0033
7 DEFLAZACORT 8 0.0031
8 PALIFERMIN 1 0.0026
9 PHENOBARBITAL SODIUM 1 0.0024
See all drugs enriched for association with MYOCARDIAL FIBROSIS

MYOCARDIAL FIBROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Paramagnetic Contrast Agent [EPC] 13 0.0028
1 Mucocutaneous Epithelial Cell Growth Factor [EPC] 1 0.0026
2 Benzodiazepine Antagonist [EPC] 2 0.0023
3 Interleukin-5 Antagonist [EPC] 1 0.0015
4 Cannabinoid [EPC] 11 0.0014
5 Actinomycin [EPC] 3 0.0014
6 Prostacycline [EPC] 1 0.0011
7 Calcitonin [EPC] 3 0.0010
8 Androgen [EPC] 23 0.0008
9 Lymphocyte Growth Factor [EPC] 1 0.0008
See all drug classes enriched for association with MYOCARDIAL FIBROSIS